Dedicated to the
Health and Welfare of All Cats
A A A
Font Size
hero-education

Control of Postoperative Pain in Cats

Oct 28, 2008
Benito-de-la-Vibora, J., B. D. Lascelles, et al. (2008). "Efficacy of tolfenamic acid and meloxicam in the control of postoperative pain following ovariohysterectomy in the cat." Vet Anaesth Analg.

This prospective, randomized, blinded and placebo-controlled study was performed at the University of Madrid, Spain to evaluate the effect of two non-steroid anti-inflammatory drugs (tolfenamic acid and meloxicam) on control of post-operative pain in cats. Sixty-nine client owned cats undergoing ovariohysterectomy were enrolled in the study. The cats were given a dose of either tolfenamic acid (Tolfedine, Vetoquinol), meloxicam (Metacam, Boehringer Ingelheim/Merial), or placebo pre-operatively and again post-operatively. Pain and wound sensitivity were assessed using standardized scales for up to 25 hours post-operatively. The meloxicam group was less painful than controls at 6 and 22 hours post-operatively; both treatment groups were less painful than controls at 25 hours. The number of cats requiring rescue analgesia did not differ between the groups. Cats receiving tolfenamic acid or meloxicam had decreased wound sensitivity compared to controls at all time points. The researchers conclude that both tolfenamic acid and meloxicam provide a similar analgesic effect for up to 24 hours post-operatively.
>> PubMed Abstract

Related articles:
Lascelles, B. D., M. H. Court, et al. (2007). "Nonsteroidal anti-inflammatory drugs in cats: a review." Vet Anaesth Analg 34(4): 228-50.
>> PubMed Abstract

Slingsby, L. and A. Waterman-Pearson (2000). "Postoperative analgesia in the cat after ovariohysterectomy by use of carprofen, ketoprofen, meloxicam or tolfenamic acid." J Small Anim Pract 41(10): 447-450.
>> PubMed Abstract
tolfenamic acid ovariohysterectomy meloxicam analgesia pain

More on cat health:

Winn Feline Foundation Library
Find us on Facebook
Follow us on Twitter
Pin with us on Pinterest
Join us on Google+